Fast and accurate method for quantitating E. coli host-cell DNA contamination in plasmid DNA preparations

BioTechniques

Volumn 26, Issue 3, 1999, Pages 518-526

  Smith III, George J ^a,c   Helf, M ^a   Nesbet, C ^b   Betita, H A ^b   Meek, J ^b   Ferre, F ^a  

^a Althea Technologies   (United States)

^b Vical   (United States)

^c GENERAL ATOMICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; PLASMID DNA; PLASMID VECTOR; PRIMER DNA;

ACCURACY; ARTICLE; ESCHERICHIA COLI; GENE EXPRESSION; GENE ISOLATION; GENE TARGETING; GENE TECHNOLOGY; GENOME IMPRINTING; INTERMETHOD COMPARISON; POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 0033004735     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/99263rr03     Document Type: Article

References (25)

1. Asahara, T., Y. Tsurumi, S. Takeshita and J.M. Isner. 1996. Naked cDNA encoding secreted proteins for intra-arterial and intramuscular gene transfer. Semin Interv. Cardiol. 1:225-232.
2. Blattner, F.R., G. Plunkett III, C.A. Bloch, N.T. Perna, V. Burland, M. Riley, J. Collado-Vides, J.D. Glasner et al. 1997. The complete genome sequence of Escherichia coli K-12. Science 277:1453-1462.
3. Center for Biological Evaluation and Research. 1996. Points to consider on plasmid DNA vaccines for preventive infectious disease indications. FDA, Bethesda.
4. Center for Biologies Evaluation and Research. 1998. Guidance for human somatic cell therapy and gene therapy, U.S. Department of Health and Human Services. FDA, Bethesda.
5. Gelfand, D.H., P.M. Holland, R.K. Saiki and R. Watson, inventors; Hoffman-LaRoche, assignee. Homogeneous assay system using the nuclease activity of a nucleic acid, polymerase. US Patent 5,210,015: 1993.
6. Gibson, U., C.A. Heid and P.M. Williams. 1996. A novel method for real time quantitative RT-PCR. Genome Res. 6:995-1001.
7. Global Program for Vaccines and Immunization. 1996. Workshop on the control and standardization of nucleic acid vaccines. World Health Organization, Geneva, Switzerland.
8. Heid, C.A., J. Stevens, K.J. Livak and P.M. Williams. 1996. Real time quantitative PCR. Genome Methods 6:986-994.
9. Henze, G., A. Borgmann, A. von Stackelberg, E. Baumgarten, B. Uchanska-Ziegler, A. Ziegler and B. WiWg. 1998. Immunotherapy of acute lymphoblastic leukemia by vaccination with autologous leukemic cells transfected with a cDNA expression plasmid coding for an allogeneic HLA class I antigen combined with interleukin-2 treatment. J. Mol. Med. 76:215-221.
10. Hoffman, S.L., D.L. Doolan, M. Sedegah, R. Wang, L.F. Scheller, A. Kumar, W.R. Weiss, T.P. Le, D.M. Klinman, J.A. Norman and R.C. Hedstrom. 1997. Toward clinical trials of DNA vaccines against malaria. Immunol. Cell Biol. 75:377-381.
11. Holland, P.M., R.D. Abramson, R. Watson and D.H. Gelfand. 1991. Detection of specific polymerase chain reaction product by utilizing the 5′ to 3′ exonuclease activity of Thermits aquaticus DNA polymerase. Proc. Natl. Acad. Sci. USA 85:7276-7280.
12. Horaud, F.N. 1995. Viral vaccines and residual cellular DNA. Biologicals 25:225-228.
13. Horn N.A., J.A. Meek, G. Budahazi and M. Marquet 1995. Cancer gene therapy using plasmid DNA: purification of DNA for human clinical trials. Hum, Gene Ther. 6:565-573.
14. Ledley, F.D. 1995. Nonviral gene therapy: the promise of genes as pharmaceutical products. Hum. Gene Ther. 6:129-1144.
15. Lee, L.G., C.R. Connell and W. Bloch. 1993. Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucleic Acids Res. 21:3761-3766.
16. Lockey, C., E. Otto and Z. Long. 1998. Real-time fluorescence detection of a single DNA molecule. BioTechniques. 24:744-746.
17. Mahvi, D.M., P.M. Sondel, N.S. Yang, M.R. Albertini, J.H. Schiller, J. Hank, J. Heiner, J. Can, W. Swain and R. Logrono. 1997. Phase I/IB study of immunization with autologous tumor cells transfected with the GM-CSF gene by particle-mediated transfer in patients with melanoma or sarcoma. Hum. Gene Ther. 8:875-891.
18. Marquet, M., N. Horn and J. Meek. 1997. Characterization of plasmid DNA vectors for use in human gene therapy. Part 1. BioPharm 10:42-50.
19. Marquet, M., N. Horn and J. Meek. 1997. Characterization of plasmid DNA vectors for use in human gene therapy. Part 2. BioPharm 10:40-45.
20. Middaugh, C.R., R.K. Evans, D.L. Montgomery and D.R. Casimiro. 1998. Analysis of plasmid DNA from a pharmaceutical perspective. J. Pharm. Sci. 87:130-146.
21. Nichols, W.W., BJ. Ledwith, S.V. Manam and P.J. Troilo. 1995. Potential DNA vaccine integration into host genome. Ann. N. Y. Acad. Sci. 772:30-39.
22. Petricciani, J.C. and F.N. Horaud. 1995. DNA, dragons, and sanity. Biologicals 23:233-238.
23. Tissue Culture Association. 1985. Monograph No. 6: abnormal cells, new products and risk. In H.E. Hopps and J.C. Petricciani (Eds.), In Vitro Cellular and Development in Biology. Gaithersburg, MD.
24. Waddill, W., W. Wright, E. Unger, A. Stopeck, E. Akporiaye, D. Harris, T. Grogan, S. Schluter, E. Hersh and S. Stahl. 1997. Human gene therapy for melanoma: CT-guided interstitial injection. AJR Am. J. Roentgenol. 169:63-67
25. Wilson, K. 1990. Preparation of genomic DNA from bacteria, p. 2.4.1-2.4.5. In F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.A. Smith, J.G. Seidman and K. Struhl. Current Protocols in Molecular Biology. John Wiley & Sons, New York.